Last: | $0.405 |
---|---|
Change Percent: | -2.39% |
Open: | $0.42 |
Close: | $0.4149 |
High: | $0.42 |
Low: | $0.3911 |
Volume: | 60,843 |
Last Trade Date Time: | 05/21/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.405 | $0.42 | $0.4149 | $0.42 | $0.3911 | 60,843 | 05-21-2024 |
$0.4149 | $0.42 | $0.4149 | $0.42 | $0.389899 | 124,094 | 05-20-2024 |
$0.403 | $0.42 | $0.403 | $0.426 | $0.396801 | 277,017 | 05-17-2024 |
$0.39 | $0.415 | $0.39 | $0.415 | $0.38 | 287,138 | 05-16-2024 |
$0.3996 | $0.4 | $0.3996 | $0.4098 | $0.38 | 178,351 | 05-15-2024 |
$0.3844 | $0.42 | $0.3844 | $0.43 | $0.36 | 499,297 | 05-14-2024 |
$0.4239 | $0.4 | $0.4239 | $0.43 | $0.395 | 114,425 | 05-13-2024 |
$0.4 | $0.43 | $0.4 | $0.4499 | $0.4 | 101,134 | 05-10-2024 |
$0.4366 | $0.42 | $0.4366 | $0.44 | $0.4101 | 64,064 | 05-09-2024 |
$0.4251 | $0.43 | $0.4251 | $0.45 | $0.42 | 137,986 | 05-08-2024 |
$0.425 | $0.42 | $0.425 | $0.4599 | $0.42 | 463,502 | 05-07-2024 |
$0.42 | $0.4299 | $0.42 | $0.4455 | $0.42 | 173,772 | 05-06-2024 |
$0.4048 | $0.4198 | $0.4048 | $0.4198 | $0.3903 | 48,518 | 05-03-2024 |
$0.4042 | $0.3916 | $0.4042 | $0.41 | $0.3808 | 117,560 | 05-02-2024 |
$0.39 | $0.41 | $0.39 | $0.4199 | $0.387 | 68,814 | 05-01-2024 |
$0.4085 | $0.42 | $0.4085 | $0.42 | $0.3926 | 55,431 | 04-30-2024 |
$0.4119 | $0.411 | $0.4119 | $0.4226 | $0.405 | 148,766 | 04-29-2024 |
$0.4282 | $0.41 | $0.4282 | $0.4289 | $0.41 | 85,255 | 04-26-2024 |
$0.4065 | $0.43 | $0.4065 | $0.4388 | $0.375 | 341,694 | 04-25-2024 |
$0.43 | $0.43 | $0.43 | $0.46 | $0.4251 | 160,867 | 04-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
AIM ImmunoTech Inc. Company Name:
AIM Stock Symbol:
NYSE Market:
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that AIM Chief Executive ...
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in two upcoming investor conferences. Details for th...